Showing 51–75 of 238 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | International Journal of Cancer ISSN: 0020-7136 / 1097-0215Top Tier | 🇨🇭Switzerland | Q2 | CAS Tier 2 | 4.9 | 1.901Q1 | 212 | 370 | 1.8% | Wiley-Liss Inc. | Profile |
| 52 | Translational Oncology ISSN: 1944-7124 / 1936-5233 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.9 | 1.383Q1 | 39 | 351 | 2.2% | Neoplasia Press | Profile |
| 53 | Cancer Imaging ISSN: 1470-7330 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.8 | 1.16Q1 | 40 | 66 | 2.9% | BioMed Central | Profile |
| 54 | Cancers ISSN: 2072-6694 | 🇨🇭Switzerland | Q2 | CAS Tier 2 | 4.8 | 1.41Q1 | 53 | 6,092 | 11.1% | MDPI (Basel, Switzerland) | Profile |
| 55 | JNCI Cancer Spectrum ISSN: 2515-5091 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.8 | 1.72Q1 | — | 104 | 0% | Oxford University Press | Profile |
| 56 | Neoplasia ISSN: 1476-5586 / 1522-8002 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | 2.284Q1 | 115 | 111 | 1.6% | Neoplasia Press | Profile |
| 57 | Neoplasia ISSN: 1522-8002 / 1476-5586 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | — | 117 | 111 | 1.6% | Neoplasia Press | Profile |
| 58 | Jco Precision Oncology ISSN: 2473-4284Top Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 4.7 | 2.082Q1 | — | 161 | 1.9% | LIPPINCOTT WILLIAMS & WILKINS | Profile |
| 59 | Medical Oncology ISSN: 1357-0560 / 1559-131X | 🇺🇸United States | Q2 | CAS Tier 3 | 4.7 | 0.963Q1 | 64 | 133 | 0% | Springer US | Profile |
| 60 | Oncologist ISSN: 1083-7159 / 1549-490XTop Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 4.7 | 1.96Q1 | 145 | 278 | 4.2% | AlphaMed Press | Profile |
| 61 | Oncology Reports ISSN: 1021-335X / 1791-2431 | 🌐Greece | Q2 | CAS Tier 3 | 4.7 | 0.887Q2 | 84 | 326 | 2.6% | Spandidos Publications | Profile |
| 62 | Oncology Research ISSN: 0965-0407 / 1555-3906 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.6 | 1.102Q1 | 52 | 27 | 0% | Cognizant Communication Corporation | Profile |
| 63 | Molecular Oncology ISSN: 1574-7891 / 1878-0261Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.5 | 1.738Q1 | 71 | 239 | 2% | John Wiley and Sons Ltd | Profile |
| 64 | Cancer Research and Treatment ISSN: 1598-2998 / 2005-9256 | 🌐South Korea | Q2 | CAS Tier 3 | 4.2 | 1.462Q1 | 28 | 119 | 4.9% | Korean Cancer Association | Profile |
| 65 | Journal of Gynecologic Oncology ISSN: 2005-0380 / 2005-0399 | 🌐South Korea | Q1 | CAS Tier 2 | 4.2 | 1.256Q1 | 30 | 64 | 5.9% | Korean Society of Gynecologic Oncology and Colposcopy | Profile |
| 66 | BMC Cancer ISSN: 1471-2407Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.1 | 1.172Q2 | 111 | 1,321 | 2.9% | BioMed Central | Profile |
| 67 | Clinical Lymphoma Myeloma & Leukemia ISSN: 2152-2650 / 2152-2669 | 🇺🇸United States | Q1 | CAS Tier 3 | 4.1 | 0.615Q2 | — | 230 | 3.7% | Cancer Media Group | Profile |
| 68 | Therapeutic Advances in Medical Oncology ISSN: 1758-8340 / 1758-8359 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.1 | 1.416Q1 | 34 | 155 | 2.3% | SAGE Publications Inc. | Profile |
| 69 | Current Hematologic Malignancy Reports ISSN: 1558-8211 / 1558-822XTop Tier | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.191Q1 | 28 | 55 | 3.7% | Springer US | Profile |
| 70 | Oncology Reviews ISSN: 1970-5557 / 1970-5565Top Tier | 🌐Italy | Q2 | CAS Tier 3 | 4 | 1.096Q2 | — | 14 | 0% | PAGEPress Publications | Profile |
| 71 | Clinical Lung Cancer ISSN: 1525-7304 / 1938-0690 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.9 | 1.362Q1 | 52 | 182 | 3% | Elsevier | Profile |
| 72 | Journal of Hepatocellular Carcinoma ISSN: 2253-5969 | 🌐New Zealand | Q2 | CAS Tier 3 | 3.9 | 0.809Q2 | — | 119 | 7.1% | DOVE MEDICAL PRESS LTD | Profile |
| 73 | BJC Reports ISSN: 2731-9377 | 🌐International | Q2 | — | 3.8 | — | — | — | N/A | SPRINGERNATURE | Profile |
| 74 | Carcinogenesis ISSN: 0143-3334 / 1460-2180 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.8 | 1.02Q1 | 189 | 152 | 0% | Oxford University Press | Profile |
| 75 | JCO Global Oncology ISSN: 2687-8941 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.8 | 1.102Q2 | — | 121 | 3.1% | American Society of Clinical Oncology | Profile |